Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
the science here beats current acne twice daily applications, once weekly application is unheard of
doubled up at 1.57. so im averaged down for this
from a faggot chart perspective it may be ready if news is good
https://finance.yahoo.com/chart/DRMA?technical=all&ncid=dcm_306158732_490172245_127172993#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
its a process it doesn't happen over night - Jeffery Dahmer
next 2 weeks if all goes well with FDA we will get our push
We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."
We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."
We look forward to receiving feedback from FDA on our End of Phase 2 meeting package by the end of June 2023. Assuming positive feedback, we plan to quickly initiate our DMT310 Phase 3 program in moderate-to-severe acne."
still here, market has twice daily creams for acne, but this is the first once weekly application, hit 2.08 other day, the number ratio has a solid effectiveness rate here. doubled up at 1.57. with FDA event in coming weeks
once weekly acne application current market has twice daily cream 10 billion market at 5.2m marketcap
we see higher volume days ahead-
- DMT310 once-weekly topical treatment demonstrated statistically significant improvements at all time points in the three primary endpoints, inflammatory lesion count, noninflammatory lesion count, and Investigator Global Assessment (IGA) -
- DMT310 significantly reduced inflammatory lesions by 45% after only 4 treatments in patients with moderate-to-severe acne -
- FDA responses to DMT310 End of Phase 2 meeting package expected by the end this month -
SAN DIEGO, CA / ACCESSWIRE / June 8, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("De
- DMT310 once-weekly topical treatment demonstrated statistically significant improvements at all time points in the three primary endpoints, inflammatory lesion count, noninflammatory lesion count, and Investigator Global Assessment (IGA) -
- DMT310 significantly reduced inflammatory lesions by 45% after only 4 treatments in patients with moderate-to-severe acne -
- FDA responses to DMT310 End of Phase 2 meeting package expected by the end this month -
SAN DIEGO, CA / ACCESSWIRE / June 8, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("De
want to see higher volume days and the milestone will see big push
known for big swings, another big swing in store here in coming weeks with this micro floater,
lets see 2 and build it up as we await for milestone
nice eod action, known for large swings, with the milestone event in june,, will see large pops ahead ,,,,,,,
strong, reversal starting
nice eod hits, we see volume it goes as we await for milestone event
not getting that fire power volume, slow reversal
$DBMM
$DBMM Watching close for penny break..could be a mover this week..
— Tommy Boy Trader (@QuabbinR) June 4, 2023
TommyBoyTrader Telegram Room..charts and conversation..its free and all are welcome!https://t.co/hgN1IiEdJp pic.twitter.com/Z0Yu6wo7Jj
had to average down here. offerings bs is how it works with bigboard biotechs. they all do it, yet run big on events, pending big event in june, hold for events with 4m OS,, hence big swings before
best to buy them in wedge chart an wait for events
ran t0 1.93 like butter, was nice comeback friday with nice action, event in june
was crucial for a comeback on friday
with this buying pressure we saw friday if it contiues can see 2
going over my 40 biotech watchlist, the offerings are everyday practice on Nasdaq imo our milestone event will be worth the wait
got loaded today, we see some action next week it goes, been a bumpy sick ride, usually i sell at loss, with big board bio techs, hold for events
nailed bottom, want to see volume pick up from here, consider offerings as a way to buy cheap shares
its starting, can see 2.00 today or by friday
the run to 3.84 was for good reason ,, want to see volume pick up, up from here its peers did big pops. this will to in coming weeks with this rare tiny market cap
I bought more,I'm loaded
was a good double up, with EPS at 2.37 hence last pop to 3.84 on that PR. selling on offering is dumb in bigboard biotech, double up and wait ,,,
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
254
|
Created
|
08/30/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |